調査レポート | • レポートコード：QYR2104Z4829 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、前立腺がん検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（PSA検査、CTC検査、免疫組織化学、PCA3検査、その他）、用途別市場規模（院内感染研究所、独立診断研究所、がん研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・前立腺がん検査の市場動向 ・企業の競争状況、市場シェア ・前立腺がん検査の種類別市場規模（PSA検査、CTC検査、免疫組織化学、PCA3検査、その他） ・前立腺がん検査の用途別市場規模（院内感染研究所、独立診断研究所、がん研究機関、その他） ・前立腺がん検査の北米市場規模2016-2027（アメリカ、カナダ） ・前立腺がん検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・前立腺がん検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・前立腺がん検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・前立腺がん検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Genomic Health、OPKO、Siemens Healthcare、DiaSorin、bioMeriux、Roche、MDx Health、Beckman Coulter、Myriad Genetics、Ambry Genetics） ・結論 |
Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
Market Analysis and Insights: Global Prostate Cancer Testing Market
The global Prostate Cancer Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Testing market.
Global Prostate Cancer Testing Scope and Market Size
Prostate Cancer Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others
Segment by Application
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PSA Tests
1.2.3 CTC Tests
1.2.4 Immunohistochemistry
1.2.5 PCA3 Tests
1.2.6 Others
1.3 Market by Application
1.3.1 Global Prostate Cancer Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Associated Labs
1.3.3 Independent Diagnostic Laboratories
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Testing Market Perspective (2016-2027)
2.2 Prostate Cancer Testing Growth Trends by Regions
2.2.1 Prostate Cancer Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Cancer Testing Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Cancer Testing Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Cancer Testing Industry Dynamic
2.3.1 Prostate Cancer Testing Market Trends
2.3.2 Prostate Cancer Testing Market Drivers
2.3.3 Prostate Cancer Testing Market Challenges
2.3.4 Prostate Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Testing Players by Revenue
3.1.1 Global Top Prostate Cancer Testing Players by Revenue (2016-2021)
3.1.2 Global Prostate Cancer Testing Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Testing Revenue
3.4 Global Prostate Cancer Testing Market Concentration Ratio
3.4.1 Global Prostate Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Testing Revenue in 2020
3.5 Prostate Cancer Testing Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Testing Product Solution and Service
3.7 Date of Enter into Prostate Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Testing Breakdown Data by Type
4.1 Global Prostate Cancer Testing Historic Market Size by Type (2016-2021)
4.2 Global Prostate Cancer Testing Forecasted Market Size by Type (2022-2027)
5 Prostate Cancer Testing Breakdown Data by Application
5.1 Global Prostate Cancer Testing Historic Market Size by Application (2016-2021)
5.2 Global Prostate Cancer Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Prostate Cancer Testing Market Size (2016-2027)
6.2 North America Prostate Cancer Testing Market Size by Type
6.2.1 North America Prostate Cancer Testing Market Size by Type (2016-2021)
6.2.2 North America Prostate Cancer Testing Market Size by Type (2022-2027)
6.2.3 North America Prostate Cancer Testing Market Size by Type (2016-2027)
6.3 North America Prostate Cancer Testing Market Size by Application
6.3.1 North America Prostate Cancer Testing Market Size by Application (2016-2021)
6.3.2 North America Prostate Cancer Testing Market Size by Application (2022-2027)
6.3.3 North America Prostate Cancer Testing Market Size by Application (2016-2027)
6.4 North America Prostate Cancer Testing Market Size by Country
6.4.1 North America Prostate Cancer Testing Market Size by Country (2016-2021)
6.4.2 North America Prostate Cancer Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Prostate Cancer Testing Market Size (2016-2027)
7.2 Europe Prostate Cancer Testing Market Size by Type
7.2.1 Europe Prostate Cancer Testing Market Size by Type (2016-2021)
7.2.2 Europe Prostate Cancer Testing Market Size by Type (2022-2027)
7.2.3 Europe Prostate Cancer Testing Market Size by Type (2016-2027)
7.3 Europe Prostate Cancer Testing Market Size by Application
7.3.1 Europe Prostate Cancer Testing Market Size by Application (2016-2021)
7.3.2 Europe Prostate Cancer Testing Market Size by Application (2022-2027)
7.3.3 Europe Prostate Cancer Testing Market Size by Application (2016-2027)
7.4 Europe Prostate Cancer Testing Market Size by Country
7.4.1 Europe Prostate Cancer Testing Market Size by Country (2016-2021)
7.4.2 Europe Prostate Cancer Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Testing Market Size (2016-2027)
8.2 Asia-Pacific Prostate Cancer Testing Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Cancer Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Cancer Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Cancer Testing Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Cancer Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Cancer Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Cancer Testing Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Cancer Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Prostate Cancer Testing Market Size (2016-2027)
9.2 Latin America Prostate Cancer Testing Market Size by Type
9.2.1 Latin America Prostate Cancer Testing Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Cancer Testing Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Cancer Testing Market Size by Type (2016-2027)
9.3 Latin America Prostate Cancer Testing Market Size by Application
9.3.1 Latin America Prostate Cancer Testing Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Cancer Testing Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Cancer Testing Market Size by Application (2016-2027)
9.4 Latin America Prostate Cancer Testing Market Size by Country
9.4.1 Latin America Prostate Cancer Testing Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Cancer Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Testing Market Size (2016-2027)
10.2 Middle East & Africa Prostate Cancer Testing Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Cancer Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Cancer Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Cancer Testing Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Cancer Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Cancer Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Cancer Testing Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Cancer Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Genomic Health
11.1.1 Genomic Health Company Details
11.1.2 Genomic Health Business Overview
11.1.3 Genomic Health Prostate Cancer Testing Introduction
11.1.4 Genomic Health Revenue in Prostate Cancer Testing Business (2016-2021)
11.1.5 Genomic Health Recent Development
11.2 OPKO
11.2.1 OPKO Company Details
11.2.2 OPKO Business Overview
11.2.3 OPKO Prostate Cancer Testing Introduction
11.2.4 OPKO Revenue in Prostate Cancer Testing Business (2016-2021)
11.2.5 OPKO Recent Development
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Details
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare Prostate Cancer Testing Introduction
11.3.4 Siemens Healthcare Revenue in Prostate Cancer Testing Business (2016-2021)
11.3.5 Siemens Healthcare Recent Development
11.4 DiaSorin
11.4.1 DiaSorin Company Details
11.4.2 DiaSorin Business Overview
11.4.3 DiaSorin Prostate Cancer Testing Introduction
11.4.4 DiaSorin Revenue in Prostate Cancer Testing Business (2016-2021)
11.4.5 DiaSorin Recent Development
11.5 bioMeriux
11.5.1 bioMeriux Company Details
11.5.2 bioMeriux Business Overview
11.5.3 bioMeriux Prostate Cancer Testing Introduction
11.5.4 bioMeriux Revenue in Prostate Cancer Testing Business (2016-2021)
11.5.5 bioMeriux Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Prostate Cancer Testing Introduction
11.6.4 Roche Revenue in Prostate Cancer Testing Business (2016-2021)
11.6.5 Roche Recent Development
11.7 MDx Health
11.7.1 MDx Health Company Details
11.7.2 MDx Health Business Overview
11.7.3 MDx Health Prostate Cancer Testing Introduction
11.7.4 MDx Health Revenue in Prostate Cancer Testing Business (2016-2021)
11.7.5 MDx Health Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Prostate Cancer Testing Introduction
11.8.4 Beckman Coulter Revenue in Prostate Cancer Testing Business (2016-2021)
11.8.5 Beckman Coulter Recent Development
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Details
11.9.2 Myriad Genetics Business Overview
11.9.3 Myriad Genetics Prostate Cancer Testing Introduction
11.9.4 Myriad Genetics Revenue in Prostate Cancer Testing Business (2016-2021)
11.9.5 Myriad Genetics Recent Development
11.10 Ambry Genetics
11.10.1 Ambry Genetics Company Details
11.10.2 Ambry Genetics Business Overview
11.10.3 Ambry Genetics Prostate Cancer Testing Introduction
11.10.4 Ambry Genetics Revenue in Prostate Cancer Testing Business (2016-2021)
11.10.5 Ambry Genetics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Prostate Cancer Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PSA Tests
Table 3. Key Players of CTC Tests
Table 4. Key Players of Immunohistochemistry
Table 5. Key Players of PCA3 Tests
Table 6. Key Players of Others
Table 7. Global Prostate Cancer Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Prostate Cancer Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Prostate Cancer Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Prostate Cancer Testing Market Share by Regions (2016-2021)
Table 11. Global Prostate Cancer Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Prostate Cancer Testing Market Share by Regions (2022-2027)
Table 13. Prostate Cancer Testing Market Trends
Table 14. Prostate Cancer Testing Market Drivers
Table 15. Prostate Cancer Testing Market Challenges
Table 16. Prostate Cancer Testing Market Restraints
Table 17. Global Prostate Cancer Testing Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Prostate Cancer Testing Market Share by Players (2016-2021)
Table 19. Global Top Prostate Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Testing as of 2020)
Table 20. Ranking of Global Top Prostate Cancer Testing Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Prostate Cancer Testing Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Prostate Cancer Testing Product Solution and Service
Table 24. Date of Enter into Prostate Cancer Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Prostate Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Prostate Cancer Testing Revenue Market Share by Type (2016-2021)
Table 28. Global Prostate Cancer Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Prostate Cancer Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Prostate Cancer Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Prostate Cancer Testing Revenue Market Share by Application (2016-2021)
Table 32. Global Prostate Cancer Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Prostate Cancer Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Prostate Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Prostate Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Prostate Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Prostate Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Prostate Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Prostate Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Prostate Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Prostate Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Prostate Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Prostate Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Prostate Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Prostate Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Prostate Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Prostate Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Prostate Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Prostate Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Prostate Cancer Testing Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Prostate Cancer Testing Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Prostate Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Prostate Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Prostate Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Prostate Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Prostate Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Prostate Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Prostate Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Prostate Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Prostate Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Prostate Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Prostate Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Prostate Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 64. Genomic Health Company Details
Table 65. Genomic Health Business Overview
Table 66. Genomic Health Prostate Cancer Testing Product
Table 67. Genomic Health Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 68. Genomic Health Recent Development
Table 69. OPKO Company Details
Table 70. OPKO Business Overview
Table 71. OPKO Prostate Cancer Testing Product
Table 72. OPKO Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 73. OPKO Recent Development
Table 74. Siemens Healthcare Company Details
Table 75. Siemens Healthcare Business Overview
Table 76. Siemens Healthcare Prostate Cancer Testing Product
Table 77. Siemens Healthcare Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 78. Siemens Healthcare Recent Development
Table 79. DiaSorin Company Details
Table 80. DiaSorin Business Overview
Table 81. DiaSorin Prostate Cancer Testing Product
Table 82. DiaSorin Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 83. DiaSorin Recent Development
Table 84. bioMeriux Company Details
Table 85. bioMeriux Business Overview
Table 86. bioMeriux Prostate Cancer Testing Product
Table 87. bioMeriux Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 88. bioMeriux Recent Development
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Prostate Cancer Testing Product
Table 92. Roche Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 93. Roche Recent Development
Table 94. MDx Health Company Details
Table 95. MDx Health Business Overview
Table 96. MDx Health Prostate Cancer Testing Product
Table 97. MDx Health Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 98. MDx Health Recent Development
Table 99. Beckman Coulter Company Details
Table 100. Beckman Coulter Business Overview
Table 101. Beckman Coulter Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 102. Beckman Coulter Recent Development
Table 103. Myriad Genetics Company Details
Table 104. Myriad Genetics Business Overview
Table 105. Myriad Genetics Prostate Cancer Testing Product
Table 106. Myriad Genetics Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 107. Myriad Genetics Recent Development
Table 108. Ambry Genetics Company Details
Table 109. Ambry Genetics Business Overview
Table 110. Ambry Genetics Prostate Cancer Testing Product
Table 111. Ambry Genetics Revenue in Prostate Cancer Testing Business (2016-2021) & (US$ Million)
Table 112. Ambry Genetics Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Testing Market Share by Type: 2020 VS 2027
Figure 2. PSA Tests Features
Figure 3. CTC Tests Features
Figure 4. Immunohistochemistry Features
Figure 5. PCA3 Tests Features
Figure 6. Others Features
Figure 7. Global Prostate Cancer Testing Market Share by Application: 2020 VS 2027
Figure 8. Hospital Associated Labs Case Studies
Figure 9. Independent Diagnostic Laboratories Case Studies
Figure 10. Cancer Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Prostate Cancer Testing Report Years Considered
Figure 13. Global Prostate Cancer Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Prostate Cancer Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Prostate Cancer Testing Market Share by Regions: 2020 VS 2027
Figure 16. Global Prostate Cancer Testing Market Share by Regions (2022-2027)
Figure 17. Global Prostate Cancer Testing Market Share by Players in 2020
Figure 18. Global Top Prostate Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Testing as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Prostate Cancer Testing Revenue in 2020
Figure 20. Global Prostate Cancer Testing Revenue Market Share by Type (2016-2021)
Figure 21. Global Prostate Cancer Testing Revenue Market Share by Type (2022-2027)
Figure 22. North America Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Prostate Cancer Testing Market Share by Type (2016-2027)
Figure 24. North America Prostate Cancer Testing Market Share by Application (2016-2027)
Figure 25. North America Prostate Cancer Testing Market Share by Country (2016-2027)
Figure 26. United States Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Prostate Cancer Testing Market Share by Type (2016-2027)
Figure 30. Europe Prostate Cancer Testing Market Share by Application (2016-2027)
Figure 31. Europe Prostate Cancer Testing Market Share by Country (2016-2027)
Figure 32. Germany Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Prostate Cancer Testing Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Prostate Cancer Testing Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Prostate Cancer Testing Market Share by Region (2016-2027)
Figure 42. China Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Prostate Cancer Testing Market Share by Type (2016-2027)
Figure 50. Latin America Prostate Cancer Testing Market Share by Application (2016-2027)
Figure 51. Latin America Prostate Cancer Testing Market Share by Country (2016-2027)
Figure 52. Mexico Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Prostate Cancer Testing Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Prostate Cancer Testing Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Prostate Cancer Testing Market Share by Country (2016-2027)
Figure 58. Turkey Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Prostate Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Genomic Health Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 62. OPKO Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 63. Siemens Healthcare Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 64. DiaSorin Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 65. bioMeriux Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 67. MDx Health Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 68. Beckman Coulter Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 69. Myriad Genetics Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 70. Ambry Genetics Revenue Growth Rate in Prostate Cancer Testing Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の子宮頸がん診断検査市場規模・現状・予測（2021年-2027年） Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Market Analysis and Insights: Global Cervical Cancer Diagnostic Tests Market The global Cervical Cancer Diagnostic Tests market size is…- 世界の前立腺がんスクリーニング市場規模・現状・予測（2021年-2027年） Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measu…
- 世界の前立腺がんスクリーニング市場規模・現状・予測（2021年-2027年） Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measu…
- 世界の甲状腺がん検査市場規模・現状・予測（2021年-2027年） Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones. The global thyroid cancer testing is expected to show significant growth over the forecast period. Increasing prevalence of thyroid cancer, technologic…
- 世界の乳がんスクリーニング検査市場規模・現状・予測（2021年-2027年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…